Page last updated: 2024-11-05

2,4-thiazolidinedione and Astrocytoma, Grade IV

2,4-thiazolidinedione has been researched along with Astrocytoma, Grade IV in 3 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Research Excerpts

ExcerptRelevanceReference
"Glioblastomas represent 15% of brain tumors."2.58Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma. ( Chellappan, DK; Dahiya, R; de Jesus Andreoli Pinto, T; Dua, K; Gupta, G; Mishra, A; Sharma, S; Singhvi, G, 2018)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Sheu, ML1
Pan, LY1
Hu, HY1
Su, HL1
Sheehan, J1
Tsou, HK1
Pan, HC1
Gupta, G1
Singhvi, G1
Chellappan, DK1
Sharma, S1
Mishra, A1
Dahiya, R1
de Jesus Andreoli Pinto, T1
Dua, K1
de Vasconcelos, A1
de Moura, LR1
Pedra, NS1
Bona, NP1
Soares, MSP1
da Silva Marques, M1
Horn, AP1
Spohr, L1
Spanevello, RM1
Stefanello, FM1
Cunico, W1

Reviews

1 review available for 2,4-thiazolidinedione and Astrocytoma, Grade IV

ArticleYear
Peroxisome proliferator-activated receptor gamma: promising target in glioblastoma.
    Panminerva medica, 2018, Volume: 60, Issue:3

    Topics: Animals; Brain Neoplasms; Glioblastoma; Glucose; Humans; Insulin; Ligands; Lipids; Mice; PPAR gamma;

2018

Other Studies

2 other studies available for 2,4-thiazolidinedione and Astrocytoma, Grade IV

ArticleYear
Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma.
    International journal of molecular sciences, 2022, Nov-04, Volume: 23, Issue:21

    Topics: Animals; Cell Cycle Proteins; Cell Line, Tumor; Diabetes Mellitus, Type 2; Glioblastoma; Glioma; Hyp

2022
Thiazolidine-2,4-dione derivative exhibits antitumoral effect and reverts behavioral and metabolic changes in a model of glioblastoma.
    Metabolic brain disease, 2022, Volume: 37, Issue:6

    Topics: Animals; Glioblastoma; Male; Rats; Rats, Wistar; Thiazolidinediones; Thiazolidines

2022